CLINUVEL unveils new global positioning
February 19, 2018 22:47 ET
|
Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 19, 2018 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX:CUV) (XETRA-DAX:UR9) (NASDAQ INTERNATIONAL DESIGNATION ADR:CLVLY) today released its new global Company...
Luxury Institute and EIX: Artificial Intelligence Demands Emergence of "Platinum Collar Worker"
January 09, 2018 08:00 ET
|
Luxury Institute, LLC;EIX (Emotional Intelligence Xpert)
NEW YORK, NY--(Marketwired - January 09, 2018) - Artificial intelligence is the big buzzword now. Academic studies trumpet that A.I. will replace humans in the workplace at unprecedented rates, while...
Concurrent Technologies Corporation Named as a 2016 World's Most Ethical Company by The Ethisphere Institute for the Fourth Year
March 07, 2016 09:11 ET
|
Concurrent Technology Corp.
JOHNSTOWN, Pa., March 7, 2016 (GLOBE NEWSWIRE) -- Concurrent Technologies Corporation (CTC) has been recognized by the Ethisphere Institute, a global leader in defining and advancing the standards of...
Eventide Launches the Eventide Multi-Asset Income Fund
July 16, 2015 12:15 ET
|
Eventide Gilead Fund
BOSTON, MA--(Marketwired - Jul 16, 2015) - Eventide is pleased to announce the launch of their third mutual fund, the Eventide Multi-Asset Income Fund. The Multi-Asset Income Fund seeks...
Eventide Gilead Fund and Eventide Healthcare & Life Sciences Fund Named WSJ Category Kings
July 15, 2015 15:51 ET
|
Eventide Gilead Fund
BOSTON, MA--(Marketwired - Jul 15, 2015) - The Eventide Gilead Fund (NASDAQ: ETGLX), (NASDAQ: ETAGX) (ETCGX, ETILX) and Eventide Healthcare & Life Sciences Fund (NASDAQ: ETNHX), (NASDAQ: ETAHX)...
Eventide Gilead Fund Best Performing Midcap Growth Mutual Fund for 2014
January 20, 2015 11:58 ET
|
Eventide Gilead Fund
BOSTON, MA--(Marketwired - Jan 20, 2015) - The Eventide Gilead Fund (NASDAQ: ETILX), a mutual fund practicing values-based investing, was the best performing midcap growth mutual fund for 2014...
Eventide Gilead Fund and Eventide Healthcare & Life Sciences Fund Named WSJ Category Kings
April 22, 2014 17:38 ET
|
Eventide Funds
BOSTON, MA--(Marketwired - Apr 22, 2014) - The Eventide Gilead Fund (NASDAQ: ETGLX) and the Eventide Healthcare & Life Sciences Fund (NASDAQ: ETAHX) were both named "Category Kings" by the Wall...
Eventide Gilead Fund Wins 2014 Lipper Fund Award
April 10, 2014 11:42 ET
|
Eventide Gilead Fund
BOSTON, MA--(Marketwired - Apr 10, 2014) - The Eventide Gilead Fund (NASDAQ: ETILX) was awarded the 2014 Lipper Fund Award for Best Mid-Cap Growth Fund for the three-year period, out of 336 eligible...
Eventide Gilead Fund and Eventide Healthcare & Life Sciences Fund Complete Calendar Year 2013 as WSJ Category Kings
January 21, 2014 11:43 ET
|
Eventide Funds
BOSTON, MA--(Marketwired - Jan 21, 2014) - The Eventide Gilead Fund's no-load share class (NASDAQ: ETGLX) and the Eventide Healthcare & Life Sciences Fund's no-load share class (NASDAQ: ETNHX)...
Eventide Gilead Fund Named Category King by the Wall Street Journal for the One-Year Period Ending September 30, 2013
October 31, 2013 13:23 ET
|
Eventide Gilead Fund
BOSTON, MA--(Marketwired - Oct 31, 2013) - The Eventide Gilead Fund, a mutual fund practicing values-based investing, was named as a "Category King" by the Wall Street Journal for the one-year...